These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23910623)

  • 1. Long-term efficacy and safety of maintenance therapy with azathioprine or cyclosporine for interstitial lung disease with diffuse cutaneous scleroderma.
    Ando K; Nakashita T; Kaneko N; Takahashi K; Motojima S
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):191-2. PubMed ID: 23910623
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine-induced pure red cell aplasia in a systemic sclerosis patient with interstitial pneumonia.
    Suto M; Nagai Y; Hasegawa M; Handa H; Ishikawa O
    J Dermatol; 2011 Mar; 38(3):285-7. PubMed ID: 21342234
    [No Abstract]   [Full Text] [Related]  

  • 3. Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis.
    Miyake N; Ando T; Ishiguro K; Maeda O; Watanabe O; Hirayama Y; Maeda K; Morise K; Matsushita M; Furukawa K; Funasaka K; Nakamura M; Miyahara R; Ohmiya N; Goto H
    World J Gastroenterol; 2015 Jan; 21(1):254-61. PubMed ID: 25574099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with pirfenidone in five patients with scleroderma-related interstitial lung disease.
    Miura Y; Saito T; Fujita K; Tsunoda Y; Tanaka T; Takoi H; Yatagai Y; Rin S; Sekine A; Hayashihara K; Nei T; Azuma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):235-8. PubMed ID: 25363224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
    Takeda Y; Tomino Y
    Nihon Rinsho; 2004 Oct; 62(10):1875-9. PubMed ID: 15500133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib mesylate (Gleevec™) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial.
    Gordon J; Udeh U; Doobay K; Magro C; Wildman H; Davids M; Mersten JN; Huang WT; Lyman S; Crow MK; Spiera RF
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-189-93. PubMed ID: 25152211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in immunosuppressive therapy.
    Marder W; McCune WJ
    Semin Respir Crit Care Med; 2007 Aug; 28(4):398-417. PubMed ID: 17764058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis.
    Daoussis D; Liossis SN; Tsamandas AC; Kalogeropoulou C; Paliogianni F; Sirinian C; Yiannopoulos G; Andonopoulos AP
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S17-22. PubMed ID: 22244622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris.
    Thakur BK; Bernardi DM; Murali MR; McClain SA; Clark RA
    J Am Acad Dermatol; 1998 Mar; 38(3):488-90. PubMed ID: 9520034
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interstitial pneumonia associated with mixed connective tissue disease--marked improvement with azathioprine].
    Suzuki M; Shimizu K; Sakamoto K; Iwase A; Aoki S; Matsuoka R; Nagayama T; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):101-5. PubMed ID: 8717301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely low dose treatment of cyclosporine for autoimmune diseases.
    Sekigawa I; Ogasawara H; Sugiyama M; Kaneko H; Hishikawa T; Tokano Y; Iida N; Hahimoto H; Hirose S
    Clin Exp Rheumatol; 1998; 16(3):352. PubMed ID: 9631766
    [No Abstract]   [Full Text] [Related]  

  • 15. Twelve-month azathioprine as maintenance therapy in early diffuse systemic sclerosis patients treated for 1-year with low dose cyclophosphamide pulse therapy.
    Paone C; Chiarolanza I; Cuomo G; Ruocco L; Vettori S; Menegozzo M; La Montagna G; Valentini G
    Clin Exp Rheumatol; 2007; 25(4):613-6. PubMed ID: 17888219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of pregnancy and the management of immunosuppressive agents to minimize fetal risks in organ transplant patients.
    Huynh LA; Min DI
    Ann Pharmacother; 1994 Dec; 28(12):1355-7. PubMed ID: 7696726
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine induced biochemical remission in childhood autoimmune hepatitis.
    Franulović OZ; Rajacić N; Lesar T; Kuna AT; Morić BV
    Coll Antropol; 2012 Sep; 36(3):973-9. PubMed ID: 23213960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment with cyclosporine in a case of progressive interstitial pneumonia associated with systemic sclerosis].
    Fujisawa T; Yagi T; Kobayashi J; Suganuma H; Saito T; Takashima Y; Nakamura Y; Suda T; Chida K; Nakamura H
    Nihon Kokyuki Gakkai Zasshi; 2003 Jul; 41(7):480-5. PubMed ID: 12931677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclosporin and diffuse alveolar interstitial lung disease].
    Losa García JE; Mateos Rodríguez F; Jiménez López A; Pérez Arellano JL
    Arch Bronconeumol; 1996; 32(6):302-6. PubMed ID: 8814824
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.